Siemens Healthineers AG
XETRA:SHL

Watchlist Manager
Siemens Healthineers AG Logo
Siemens Healthineers AG
XETRA:SHL
Watchlist
Price: 50.82 EUR 0.43% Market Closed
Market Cap: 56.8B EUR
Have any thoughts about
Siemens Healthineers AG?
Write Note

Intrinsic Value

The intrinsic value of one SHL stock under the Base Case scenario is 74.29 EUR. Compared to the current market price of 50.82 EUR, Siemens Healthineers AG is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SHL Intrinsic Value
74.29 EUR
Undervaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Siemens Healthineers AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SHL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SHL?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Siemens Healthineers AG

Provide an overview of the primary business activities
of Siemens Healthineers AG.

What unique competitive advantages
does Siemens Healthineers AG hold over its rivals?

What risks and challenges
does Siemens Healthineers AG face in the near future?

Has there been any significant insider trading activity
in Siemens Healthineers AG recently?

Summarize the latest earnings call
of Siemens Healthineers AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Siemens Healthineers AG.

Provide P/S
for Siemens Healthineers AG.

Provide P/E
for Siemens Healthineers AG.

Provide P/OCF
for Siemens Healthineers AG.

Provide P/FCFE
for Siemens Healthineers AG.

Provide P/B
for Siemens Healthineers AG.

Provide EV/S
for Siemens Healthineers AG.

Provide EV/GP
for Siemens Healthineers AG.

Provide EV/EBITDA
for Siemens Healthineers AG.

Provide EV/EBIT
for Siemens Healthineers AG.

Provide EV/OCF
for Siemens Healthineers AG.

Provide EV/FCFF
for Siemens Healthineers AG.

Provide EV/IC
for Siemens Healthineers AG.

Show me price targets
for Siemens Healthineers AG made by professional analysts.

What are the Revenue projections
for Siemens Healthineers AG?

How accurate were the past Revenue estimates
for Siemens Healthineers AG?

What are the Net Income projections
for Siemens Healthineers AG?

How accurate were the past Net Income estimates
for Siemens Healthineers AG?

What are the EPS projections
for Siemens Healthineers AG?

How accurate were the past EPS estimates
for Siemens Healthineers AG?

What are the EBIT projections
for Siemens Healthineers AG?

How accurate were the past EBIT estimates
for Siemens Healthineers AG?

Compare the revenue forecasts
for Siemens Healthineers AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Siemens Healthineers AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Siemens Healthineers AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Siemens Healthineers AG compared to its peers.

Compare the P/E ratios
of Siemens Healthineers AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Siemens Healthineers AG with its peers.

Analyze the financial leverage
of Siemens Healthineers AG compared to its main competitors.

Show all profitability ratios
for Siemens Healthineers AG.

Provide ROE
for Siemens Healthineers AG.

Provide ROA
for Siemens Healthineers AG.

Provide ROIC
for Siemens Healthineers AG.

Provide ROCE
for Siemens Healthineers AG.

Provide Gross Margin
for Siemens Healthineers AG.

Provide Operating Margin
for Siemens Healthineers AG.

Provide Net Margin
for Siemens Healthineers AG.

Provide FCF Margin
for Siemens Healthineers AG.

Show all solvency ratios
for Siemens Healthineers AG.

Provide D/E Ratio
for Siemens Healthineers AG.

Provide D/A Ratio
for Siemens Healthineers AG.

Provide Interest Coverage Ratio
for Siemens Healthineers AG.

Provide Altman Z-Score Ratio
for Siemens Healthineers AG.

Provide Quick Ratio
for Siemens Healthineers AG.

Provide Current Ratio
for Siemens Healthineers AG.

Provide Cash Ratio
for Siemens Healthineers AG.

What is the historical Revenue growth
over the last 5 years for Siemens Healthineers AG?

What is the historical Net Income growth
over the last 5 years for Siemens Healthineers AG?

What is the current Free Cash Flow
of Siemens Healthineers AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Siemens Healthineers AG.

Business Breakdown

Siemens Healthineers AG stands at the forefront of medical technology, championing innovation in healthcare that dramatically enhances patient outcomes around the globe. Established as a subsidiary of the industrial giant Siemens AG, the company has carved out its own identity as a leader in diagnostic imaging, laboratory diagnostics, and digital health services. With a rich history spanning over a century, Siemens Healthineers has continuously evolved, investing heavily in research and development to produce cutting-edge technologies such as advanced imaging equipment like MRI and CT scanners. This relentless pursuit of excellence equips healthcare providers with the tools necessary to deli...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Siemens Healthineers AG

Current Assets 14.2B
Cash & Short-Term Investments 2.3B
Receivables 6.5B
Other Current Assets 5.4B
Non-Current Assets 32.4B
Long-Term Investments 1.6B
PP&E 4.4B
Intangibles 25.4B
Other Non-Current Assets 1.1B
Current Liabilities 11.2B
Accounts Payable 2B
Other Current Liabilities 9.2B
Non-Current Liabilities 17.2B
Long-Term Debt 14.4B
Other Non-Current Liabilities 2.8B
Efficiency

Earnings Waterfall
Siemens Healthineers AG

Revenue
22.1B EUR
Cost of Revenue
-13.7B EUR
Gross Profit
8.4B EUR
Operating Expenses
-5.6B EUR
Operating Income
2.7B EUR
Other Expenses
-859m EUR
Net Income
1.9B EUR

Free Cash Flow Analysis
Siemens Healthineers AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q4, Siemens Healthineers achieved impressive revenue growth of 7% year-over-year, with a notable 16% increase in adjusted EPS. Despite challenges in China, margins expanded nearly 100 basis points, driven primarily by Imaging and Advanced Therapies. Free cash flow more than doubled, signaling operational efficiency. Looking ahead, the company anticipates 5-6% revenue growth and adjusted EPS of EUR 2.35 to EUR 2.50 for fiscal 2025, while also addressing a soft Q1 expectation. Key innovations in imaging technologies suggest potential future gains despite ongoing market challenges.

What is Earnings Call?
Fundamental Scores

SHL Profitability Score
Profitability Due Diligence

Siemens Healthineers AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
53/100
Profitability
Score

Siemens Healthineers AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

SHL Solvency Score
Solvency Due Diligence

Siemens Healthineers AG's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
High Interest Coverage
47/100
Solvency
Score

Siemens Healthineers AG's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SHL Price Targets Summary
Siemens Healthineers AG

Wall Street analysts forecast SHL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SHL is 60.05 EUR with a low forecast of 50.5 EUR and a high forecast of 69.3 EUR.

Lowest
Price Target
50.5 EUR
1% Downside
Average
Price Target
60.05 EUR
18% Upside
Highest
Price Target
69.3 EUR
36% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SHL?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SHL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SHL Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

SHL News

Other Videos

Profile

Siemens Healthineers AG Logo
Siemens Healthineers AG

Country

Germany

Industry

Health Care

Market Cap

56.7B EUR

Dividend Yield

1.87%

Description

Siemens Healthineers AG operates as a holding company. The company is headquartered in Erlangen, Bayern and currently employs 66,800 full-time employees. The company went IPO on 2018-03-16. The firm offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. The company provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company develops its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The firm is active worldwide.

Contact

BAYERN
Erlangen
Henkestrasse 127
www.siemens-healthineers.com

IPO

2018-03-16

Employees

66 800

Officers

President, CEO & Chairman of Management Board
Dr. Bernhard Montag
CFO & Member of Management Board
Dr. Jochen Schmitz Ph.D.
Chief Human Resources Officer, Labor Director & Member of Management Board
Ms. Darleen Caron
Member of Management Board
Ms. Elisabeth Staudinger-Leibrecht M.A.
Head of Investor Relations
Mr. Marc Koebernick
Executive Vice President of Finance
Christian Klaussner
Show More
Head of Imaging
Andre Hartung
Head of Advanced Therapies
Carsten Bertram
Head of Americas
Mr. David C. Pacitti M.B.A.
Head of Diagnostics
Ms. Sharon J. Bracken
Show Less

See Also

Discover More
What is the Intrinsic Value of one SHL stock?

The intrinsic value of one SHL stock under the Base Case scenario is 74.29 EUR.

Is SHL stock undervalued or overvalued?

Compared to the current market price of 50.82 EUR, Siemens Healthineers AG is Undervalued by 32%.

Back to Top